BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 11689688)

  • 1. Interaction between cyclin T1 and SCF(SKP2) targets CDK9 for ubiquitination and degradation by the proteasome.
    Kiernan RE; Emiliani S; Nakayama K; Castro A; Labbé JC; Lorca T; Nakayama Ki K; Benkirane M
    Mol Cell Biol; 2001 Dec; 21(23):7956-70. PubMed ID: 11689688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The F-box protein Skp2 is a ubiquitylation target of a Cul1-based core ubiquitin ligase complex: evidence for a role of Cul1 in the suppression of Skp2 expression in quiescent fibroblasts.
    Wirbelauer C; Sutterlüty H; Blondel M; Gstaiger M; Peter M; Reymond F; Krek W
    EMBO J; 2000 Oct; 19(20):5362-75. PubMed ID: 11032804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of human CUL-1 and ubiquitin-conjugating enzyme CDC34 with the F-box protein p45(SKP2): evidence for evolutionary conservation in the subunit composition of the CDC34-SCF pathway.
    Lisztwan J; Marti A; Sutterlüty H; Gstaiger M; Wirbelauer C; Krek W
    EMBO J; 1998 Jan; 17(2):368-83. PubMed ID: 9430629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitination and degradation of the substrate recognition subunits of SCF ubiquitin-protein ligases.
    Zhou P; Howley PM
    Mol Cell; 1998 Nov; 2(5):571-80. PubMed ID: 9844630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kip1 degradation via the ubiquitin-proteasome pathway.
    Tam SW; Theodoras AM; Pagano M
    Leukemia; 1997 Apr; 11 Suppl 3():363-6. PubMed ID: 9209391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation of B-Myb by ubiquitin-mediated proteolysis: involvement of the Cdc34-SCF(p45Skp2) pathway.
    Charrasse S; Carena I; Brondani V; Klempnauer KH; Ferrari S
    Oncogene; 2000 Jun; 19(26):2986-95. PubMed ID: 10871850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin-dependent kinase and Cks/Suc1 interact with the proteasome in yeast to control proteolysis of M-phase targets.
    Kaiser P; Moncollin V; Clarke DJ; Watson MH; Bertolaet BL; Reed SI; Bailly E
    Genes Dev; 1999 May; 13(9):1190-202. PubMed ID: 10323869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2).
    Tedesco D; Lukas J; Reed SI
    Genes Dev; 2002 Nov; 16(22):2946-57. PubMed ID: 12435635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
    Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
    Oncogene; 1999 May; 18(21):3290-302. PubMed ID: 10359535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDK9 is constitutively expressed throughout the cell cycle, and its steady-state expression is independent of SKP2.
    Garriga J; Bhattacharya S; Calbó J; Marshall RM; Truongcao M; Haines DS; Graña X
    Mol Cell Biol; 2003 Aug; 23(15):5165-73. PubMed ID: 12861003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional regulation by targeted recruitment of cyclin-dependent CDK9 kinase in vivo.
    Majello B; Napolitano G; Giordano A; Lania L
    Oncogene; 1999 Aug; 18(32):4598-605. PubMed ID: 10467404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation.
    Clurman BE; Sheaff RJ; Thress K; Groudine M; Roberts JM
    Genes Dev; 1996 Aug; 10(16):1979-90. PubMed ID: 8769642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.
    Pagano M; Tam SW; Theodoras AM; Beer-Romero P; Del Sal G; Chau V; Yew PR; Draetta GF; Rolfe M
    Science; 1995 Aug; 269(5224):682-5. PubMed ID: 7624798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription.
    O'Keeffe B; Fong Y; Chen D; Zhou S; Zhou Q
    J Biol Chem; 2000 Jan; 275(1):279-87. PubMed ID: 10617616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitin-dependent proteolysis and cell cycle control in yeast.
    Chun KT; Mathias N; Goebl MG
    Prog Cell Cycle Res; 1996; 2():115-27. PubMed ID: 9552389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spike of S phase cyclin Cig2 expression at the G1-S border in fission yeast requires both APC and SCF ubiquitin ligases.
    Yamano H; Kitamura K; Kominami K; Lehmann A; Katayama S; Hunt T; Toda T
    Mol Cell; 2000 Dec; 6(6):1377-87. PubMed ID: 11163211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional inactivation of Cdk9 through oligomerization chain reaction.
    Napolitano G; Mazzocco A; Fraldi A; Majello B; Lania L
    Oncogene; 2003 Jul; 22(31):4882-8. PubMed ID: 12894230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation- and ubiquitin-dependent degradation of the cyclin-dependent kinase inhibitor Far1p in budding yeast.
    Henchoz S; Chi Y; Catarin B; Herskowitz I; Deshaies RJ; Peter M
    Genes Dev; 1997 Nov; 11(22):3046-60. PubMed ID: 9367986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway.
    Diehl JA; Zindy F; Sherr CJ
    Genes Dev; 1997 Apr; 11(8):957-72. PubMed ID: 9136925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A splice variant of Skp2 is retained in the cytoplasm and fails to direct cyclin D1 ubiquitination in the uterine cancer cell line SK-UT.
    Ganiatsas S; Dow R; Thompson A; Schulman B; Germain D
    Oncogene; 2001 Jun; 20(28):3641-50. PubMed ID: 11439327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.